© Francois Guenet / Inserm
Appointed by the French Council of Ministers on November 26, 2018, Gilles Bloch took up his post as Chairman and Chief Executive Officer of Inserm on January 2, 2019.
A graduate of the École Polytechnique, doctor, and researcher specializing in medical imaging, Gilles Bloch spent a large part of his career at the French Atomic Energy Commission before taking on major roles within research policy, including heading up the French National Research Agency upon its creation, and then being appointed Head of Research and Innovation at the Ministry of Higher Education and Research. Since 2015, he has chaired Université Paris-Saclay.
On the occasion of his new role, Gilles Bloch will present his New Year greetings to the press on Tuesday January 15, 2019 at 9 a.m., at Inserm headquarters.
Press contact and registration: firstname.lastname@example.org
Over the last few years, Inserm has become a world leader in the field of sport and health research. Here we provide an overview of recent work at the Institute to mark the Sport Unlimitech festival for sport and innovation, which is ...
At a time when the Sars-CoV-2 epidemic is continuing to spread, France’s Alliance for Life Sciences and Health (Aviesan) is mobilizing to accelerate research into the virus and COVID-19 disease through REACTing – a consortium coordinated by Inserm. The Scientific Advisory Board ...